WASHINGTON (CN) - As reports of serious complications continue to rise, the Food and Drug Administration has issued two orders to manufacturers to strengthen requirements for transvaginal surgical ...

After issuing safety warnings, the FDA may revoke its approvals of transvaginal mesh devices made by Boston Scientific and Johnson & Johnson, according to a Mass Device report. The devices, used to ...

San Diego Hall of Justice, 330 West Broadway, San Diego (Photo: Shutterstock.com) A lawyer for the state of California asked a San Diego judge Monday to impose more than $700 million in civil ...

NEW YORK (Reuters) - Medtronic Plc's Covidien unit has agreed to settle some of the more than 11,000 claims involving its transvaginal mesh devices, which patients allege caused severe and painful ...

(Reuters) - A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. TRENTON, N.J. (AP) — Johnson & Johnson has ...

CHICAGO — The ban on further sales of transvaginal mesh for pelvic organ prolapse (POP) imposed by the US Food and Drug Administration (FDA) last month has some people cheering, some saying that an ...

The first transvaginal mesh trial involving a state attorney general starts this month, with the state of California suing Johnson & Johnson's Ethicon Inc. The bench trial, with opening statements set ...

TRENTON, N.J. >> Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women’s sagging pelvic organs.

NEW YORK, June 26, 2017 /PRNewswire/ -- Transvaginal mesh lawsuits filed against Johnson & Johnson and its Ethicon, Inc. subsidiary continue to move forward in a mass tort litigation now underway in ...

Trenton, N.J. – Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women’s sagging pelvic organs.